Evidence map›Paper›PMID 34922898›Full record

Trial reportEuropean urology focus2022

Prostate Surgery for Men with Lower Urinary Tract Symptoms: Do We Need Urodynamics to Find the Right Candidates? Exploratory Findings from the UPSTREAM Trial.

Grace J Young, Chris Metcalfe, J Athene Lane, Amanda L Lewis, Paul Abrams, Peter S Blair, Hiroki Ito, Christopher Chapple, Marcus J Drake

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European urology focus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Use of Uroflowmetry as a Diagnostic Test.Current urology reports · 2024
    Review
  11. Efficacy of GreenLight laser prostatectomy in urinary retention.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Grace J YoungBristol Medical School, University of Bristol, Bristol, UK; Bristol Trials Centre (BRTC), University of Bristol, Bristol, UK.
Chris MetcalfeBristol Medical School, University of Bristol, Bristol, UK; Bristol Trials Centre (BRTC), University of Bristol, Bristol, UK.
J Athene LaneBristol Medical School, University of Bristol, Bristol, UK; Bristol Trials Centre (BRTC), University of Bristol, Bristol, UK.
Amanda L LewisBristol Medical School, University of Bristol, Bristol, UK; Bristol Trials Centre (BRTC), University of Bristol, Bristol, UK.
Paul AbramsBristol Urological Institute, Level 3, Learning and Research Building, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Peter S BlairBristol Medical School, University of Bristol, Bristol, UK; Bristol Trials Centre (BRTC), University of Bristol, Bristol, UK.
Hiroki ItoBristol Urological Institute, Level 3, Learning and Research Building, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Christopher ChappleSheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, UK.
Marcus J DrakeBristol Medical School, University of Bristol, Bristol, UK; Bristol Urological Institute, Level 3, Learning and Research Building, North Bristol NHS Trust, Southmead Hospital, Bristol, UK. Electronic address: marcus.drake@bristol.ac.uk.
University of Bristol · GBNorth Bristol NHS Trust · GBRoyal Hallamshire Hospital · GB

Funding

Department of Health 12/140/01
6 · The paper itself

Abstract

backgroundIdentifying men whose lower urinary tract symptoms (LUTS) may benefit from surgery is challenging.

objectiveTo identify routine diagnostic and urodynamic measures associated with treatment decision-making, and outcome, in exploratory analyses of the UPSTREAM trial. DESIGN, SETTING, AND

participantsA randomised controlled trial was conducted including 820 men, considering surgery for LUTS, across 26 hospitals in England (ISCTRN56164274).

interventionMen were randomised to a routine care (RC) diagnostic pathway (n = 393) or a pathway that included urodynamics (UDS) in addition to RC (n = 427). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Men underwent uroflowmetry and completed symptom questionnaires, at baseline and 18 mo after randomisation. Regression models identified baseline clinical and symptom measures that predicted recommendation for surgery and/or surgical outcome (measured by the International Prostate Symptom Score [IPSS]). We explored the association between UDS and surgical outcome in subgroups defined by routine measures. RESULTS AND LIMITATIONS: The recommendation for surgery could be predicted successfully in the RC and UDS groups (area under the receiver operating characteristic curve 0.78), with maximum flow rate (Q

conclusionsTreatment decisions were informed with UDS, when available, but without evidence of change in the decisions reached. Despite the small group sizes, exploratory analyses suggest that selective use of UDS could detect obstructive pathology, missed by routine measures, in certain subgroups. PATIENT SUMMARY: Baseline clinical and symptom measurements were able to predict treatment decisions. The addition of urodynamic test results, while useful, did not generally lead to better surgical decisions and outcomes over routine tests alone.

Indexed as

Lower Urinary Tract SymptomsUrinary Bladder Neck ObstructionHumansMaleProstateUrinary BladderUrodynamicsLower urinary tract symptomsPatient-reported outcome measuresUrethral obstructionUrodynamicsUrologic surgical procedures

Identifiers

PMID34922898
PMCPMC9705260
OpenAlexW4200484875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.